Triple vessel disease, stent implantation, hypertension, eGFR, and uric acid are independent predictors of MACE in CAD patients that should be monitored early.
No takes yet. Share an insight, caveat, or question.
May aid CAD risk stratification; leaves open whether modifying these factors reduces MACE.
Tsai et al. (2017) studied this question.